Skip to content

A confirmation study of the influence for blood vessel by consumption of test food

A confirmation study of the influence for blood vessel by consumption of test food - A confirmation study of the influence for blood vessel by consumption of test food

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036448
Enrollment
24
Registered
2020-04-10
Start date
2019-04-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake two capsules of test food a day for 4 weeks. Intake two capsules of control food a day for 4 weeks.

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Healthy males aged over 20 years old when consent acquisition. 2) Subjects who have athletic activity. 3) Subjects who have received enough explanation about this study and were able to understand that, then giving written informed consent.

Exclusion criteria

Exclusion criteria: 1)Subjects who are given continuous treatment by taking medicines. 2)Subjects who have previous and/or current medical history of serious disease (e.g.,digestive organ,circulatory organ,respiratory organ and urinary organ etc.). 3)Subjects who excessive alcohol intake. 4)Subjects who have extremely irregular dining habits,and subjects who have midnight work or irregular shift work. 5)Subjects who have previous medical history of drug and/or food allergy. 6)Subjects who regularly having medicines, quasi-drugs,food for specified health uses,foods with function claim,health food and/or supplements. 7)Subjects who participated within one month prior to the current study and/or who plan to participate the other clinical tests. 8)Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 9)Subjects who donated over 400mL blood and/or blood components within the last three month to the current study. 10)Subjects who will be collected over 1200mL blood and/or blood components,when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 11)Others who have been determined ineligible by principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
%FMD

Secondary

MeasureTime frame
RHI value AI value d-ROMs BAP The incidence of side effects and/or adverse events.

Countries

Japan

Contacts

Public ContactMakoto Ichinohe

CPCC Company Limited Sales & Planning Division

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026